Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.27 | 0.27 | 0.00 |
Stocks | 97.64 | 97.64 | 0.00 |
Other | 2.09 | 2.24 | 0.15 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.77 | 20.37 |
Price to Book | 4.46 | 4.47 |
Price to Sales | 4.01 | 2.47 |
Price to Cash Flow | 16.18 | 17.30 |
Dividend Yield | 1.09 | 1.11 |
5 Years Earnings Growth | 6.94 | 10.37 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.85 | 99.53 |
Consumer Defensive | 0.15 | 0.34 |
Number of long holdings: 198
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 13.97 | 166.09 | -0.96% | |
Amgen | US0311621009 | 8.06 | 301.08 | +0.13% | |
Krystal Biotech | US5011471027 | 6.77 | 181.96 | +2.52% | |
Regeneron Pharma | US75886F1075 | 4.20 | 1,027.67 | +1.70% | |
Vertex | US92532F1003 | 3.36 | 475.79 | -1.19% | |
Gilead | US3755581036 | 2.25 | 64.34 | -0.85% | |
Alnylam | US02043Q1076 | 2.18 | 159.04 | +1.67% | |
Ascendis Pharma AS | US04351P1012 | 2.11 | 131.27 | -0.50% | |
UCB | BE0003739530 | 1.66 | 135.25 | +2.93% | |
Zealand Pharma | DK0060257814 | 1.61 | 611.50 | -5.49% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 512.39B | 11.29 | 9.55 | 12.68 | ||
Fidelity Contrafund | 128.94B | 20.29 | 10.80 | 14.71 | ||
Fidelity Contrafund K | 128.94B | 20.28 | 10.86 | 14.80 | ||
Fidelity Total Market Index Instl b | 87.5B | 10.19 | 7.73 | 12.03 | ||
Strategic Advisers Core | 59.85B | 12.34 | 9.59 | 12.55 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review